Survivorship and complications of treatment in breast cancer.
Identifieur interne : 007E66 ( Main/Exploration ); précédent : 007E65; suivant : 007E67Survivorship and complications of treatment in breast cancer.
Auteurs : Ewa Mrozek [États-Unis] ; Charles L. ShapiroSource :
- Clinical advances in hematology & oncology : H&O [ 1543-0790 ] ; 2005.
Descripteurs français
- KwdFr :
- Adulte, Antinéoplasiques hormonaux (effets indésirables), Complications postopératoires (étiologie), Essais contrôlés randomisés comme sujet, Fatigue (), Femelle, Grossesse, Hormones corticosurrénaliennes (usage thérapeutique), Humains, Insuffisance ovarienne primitive (), Lymphoedème (), Lymphoedème (étiologie), Lésions radio-induites (étiologie), Maladies cardiovasculaires (étiologie), Mastectomie, Neuropathies du plexus brachial (étiologie), Ostéoporose (), Pneumopathie radique (traitement médicamenteux), Pneumopathie radique (étiologie), Protocoles de polychimiothérapie antinéoplasique (effets indésirables), Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique), Radiothérapie (), Radiothérapie (effets indésirables), Seconde tumeur primitive (épidémiologie), Seconde tumeur primitive (étiologie), Survivants, Thrombose (), Traitement médicamenteux adjuvant (effets indésirables), Troubles de la cognition (), Tumeurs de l'endomètre (), Tumeurs du sein (), Tumeurs du sein (mortalité), Tumeurs du sein (radiothérapie), Tumeurs du sein (traitement médicamenteux), Tumeurs radio-induites (épidémiologie), Tumeurs radio-induites (étiologie).
- MESH :
- effets indésirables : Antinéoplasiques hormonaux, Protocoles de polychimiothérapie antinéoplasique, Radiothérapie, Traitement médicamenteux adjuvant.
- mortalité : Tumeurs du sein.
- radiothérapie : Tumeurs du sein.
- traitement médicamenteux : Pneumopathie radique, Tumeurs du sein.
- usage thérapeutique : Hormones corticosurrénaliennes, Protocoles de polychimiothérapie antinéoplasique.
- épidémiologie : Seconde tumeur primitive, Tumeurs radio-induites.
- étiologie : Complications postopératoires, Lymphoedème, Lésions radio-induites, Maladies cardiovasculaires, Neuropathies du plexus brachial, Pneumopathie radique, Seconde tumeur primitive, Tumeurs radio-induites.
- Adulte, Essais contrôlés randomisés comme sujet, Fatigue, Femelle, Grossesse, Humains, Insuffisance ovarienne primitive, Lymphoedème, Mastectomie, Ostéoporose, Radiothérapie, Survivants, Thrombose, Troubles de la cognition, Tumeurs de l'endomètre, Tumeurs du sein.
English descriptors
- KwdEn :
- Adrenal Cortex Hormones (therapeutic use), Adult, Antineoplastic Agents, Hormonal (adverse effects), Antineoplastic Combined Chemotherapy Protocols (adverse effects), Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Brachial Plexus Neuropathies (etiology), Breast Neoplasms (drug therapy), Breast Neoplasms (mortality), Breast Neoplasms (radiotherapy), Breast Neoplasms (surgery), Breast Neoplasms (therapy), Cardiovascular Diseases (etiology), Chemotherapy, Adjuvant (adverse effects), Cognition Disorders (chemically induced), Endometrial Neoplasms (chemically induced), Fatigue (chemically induced), Female, Humans, Lymphedema (etiology), Lymphedema (therapy), Mastectomy, Neoplasms, Radiation-Induced (epidemiology), Neoplasms, Radiation-Induced (etiology), Neoplasms, Second Primary (epidemiology), Neoplasms, Second Primary (etiology), Osteoporosis (chemically induced), Postoperative Complications (etiology), Pregnancy, Primary Ovarian Insufficiency (chemically induced), Radiation Injuries (etiology), Radiation Pneumonitis (drug therapy), Radiation Pneumonitis (etiology), Radiotherapy (adverse effects), Radiotherapy (methods), Randomized Controlled Trials as Topic, Survivors, Thrombosis (chemically induced).
- MESH :
- chemical , adverse effects : Antineoplastic Agents, Hormonal.
- chemical , therapeutic use : Adrenal Cortex Hormones.
- adverse effects : Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Adjuvant, Radiotherapy.
- chemically induced : Cognition Disorders, Endometrial Neoplasms, Fatigue, Osteoporosis, Primary Ovarian Insufficiency, Thrombosis.
- drug therapy : Breast Neoplasms, Radiation Pneumonitis.
- epidemiology : Neoplasms, Radiation-Induced, Neoplasms, Second Primary.
- etiology : Brachial Plexus Neuropathies, Cardiovascular Diseases, Lymphedema, Neoplasms, Radiation-Induced, Neoplasms, Second Primary, Postoperative Complications, Radiation Injuries, Radiation Pneumonitis.
- methods : Radiotherapy.
- mortality : Breast Neoplasms.
- radiotherapy : Breast Neoplasms.
- surgery : Breast Neoplasms.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols.
- therapy : Breast Neoplasms, Lymphedema.
- Adult, Female, Humans, Mastectomy, Pregnancy, Randomized Controlled Trials as Topic, Survivors.
Abstract
The majority of women treated today for breast cancer are long-term survivors. The overall benefits of adjuvant therapy in women with breast cancer favor treatment even in the subset of patients with node-negative invasive breast cancer. The short- and long-term side effects of combined modality treatment have a significant impact on morbidity and quality of life. Continued emphasis on improving survival, decreasing recurrence, and minimizing treatment toxicity are the goals of ongoing breast cancer research.
PubMed: 16166992
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003C01
- to stream PubMed, to step Curation: 003C01
- to stream PubMed, to step Checkpoint: 003C01
- to stream Ncbi, to step Merge: 001F58
- to stream Ncbi, to step Curation: 001F58
- to stream Ncbi, to step Checkpoint: 001F58
- to stream Main, to step Merge: 008070
- to stream Main, to step Curation: 007E66
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Survivorship and complications of treatment in breast cancer.</title>
<author><name sortKey="Mrozek, Ewa" sort="Mrozek, Ewa" uniqKey="Mrozek E" first="Ewa" last="Mrozek">Ewa Mrozek</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Hematology/Oncology and Comprehensive Breast Health Services, Ohio State University Medical Center, Columbus, OH 43210, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Hematology/Oncology and Comprehensive Breast Health Services, Ohio State University Medical Center, Columbus, OH 43210</wicri:regionArea>
<placeName><region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shapiro, Charles L" sort="Shapiro, Charles L" uniqKey="Shapiro C" first="Charles L" last="Shapiro">Charles L. Shapiro</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:16166992</idno>
<idno type="pmid">16166992</idno>
<idno type="wicri:Area/PubMed/Corpus">003C01</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003C01</idno>
<idno type="wicri:Area/PubMed/Curation">003C01</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003C01</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003C01</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003C01</idno>
<idno type="wicri:Area/Ncbi/Merge">001F58</idno>
<idno type="wicri:Area/Ncbi/Curation">001F58</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001F58</idno>
<idno type="wicri:doubleKey">1543-0790:2005:Mrozek E:survivorship:and:complications</idno>
<idno type="wicri:Area/Main/Merge">008070</idno>
<idno type="wicri:Area/Main/Curation">007E66</idno>
<idno type="wicri:Area/Main/Exploration">007E66</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Survivorship and complications of treatment in breast cancer.</title>
<author><name sortKey="Mrozek, Ewa" sort="Mrozek, Ewa" uniqKey="Mrozek E" first="Ewa" last="Mrozek">Ewa Mrozek</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Hematology/Oncology and Comprehensive Breast Health Services, Ohio State University Medical Center, Columbus, OH 43210, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Hematology/Oncology and Comprehensive Breast Health Services, Ohio State University Medical Center, Columbus, OH 43210</wicri:regionArea>
<placeName><region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shapiro, Charles L" sort="Shapiro, Charles L" uniqKey="Shapiro C" first="Charles L" last="Shapiro">Charles L. Shapiro</name>
</author>
</analytic>
<series><title level="j">Clinical advances in hematology & oncology : H&O</title>
<idno type="ISSN">1543-0790</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenal Cortex Hormones (therapeutic use)</term>
<term>Adult</term>
<term>Antineoplastic Agents, Hormonal (adverse effects)</term>
<term>Antineoplastic Combined Chemotherapy Protocols (adverse effects)</term>
<term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term>
<term>Brachial Plexus Neuropathies (etiology)</term>
<term>Breast Neoplasms (drug therapy)</term>
<term>Breast Neoplasms (mortality)</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Breast Neoplasms (therapy)</term>
<term>Cardiovascular Diseases (etiology)</term>
<term>Chemotherapy, Adjuvant (adverse effects)</term>
<term>Cognition Disorders (chemically induced)</term>
<term>Endometrial Neoplasms (chemically induced)</term>
<term>Fatigue (chemically induced)</term>
<term>Female</term>
<term>Humans</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (therapy)</term>
<term>Mastectomy</term>
<term>Neoplasms, Radiation-Induced (epidemiology)</term>
<term>Neoplasms, Radiation-Induced (etiology)</term>
<term>Neoplasms, Second Primary (epidemiology)</term>
<term>Neoplasms, Second Primary (etiology)</term>
<term>Osteoporosis (chemically induced)</term>
<term>Postoperative Complications (etiology)</term>
<term>Pregnancy</term>
<term>Primary Ovarian Insufficiency (chemically induced)</term>
<term>Radiation Injuries (etiology)</term>
<term>Radiation Pneumonitis (drug therapy)</term>
<term>Radiation Pneumonitis (etiology)</term>
<term>Radiotherapy (adverse effects)</term>
<term>Radiotherapy (methods)</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Survivors</term>
<term>Thrombosis (chemically induced)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Antinéoplasiques hormonaux (effets indésirables)</term>
<term>Complications postopératoires (étiologie)</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Fatigue ()</term>
<term>Femelle</term>
<term>Grossesse</term>
<term>Hormones corticosurrénaliennes (usage thérapeutique)</term>
<term>Humains</term>
<term>Insuffisance ovarienne primitive ()</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (étiologie)</term>
<term>Lésions radio-induites (étiologie)</term>
<term>Maladies cardiovasculaires (étiologie)</term>
<term>Mastectomie</term>
<term>Neuropathies du plexus brachial (étiologie)</term>
<term>Ostéoporose ()</term>
<term>Pneumopathie radique (traitement médicamenteux)</term>
<term>Pneumopathie radique (étiologie)</term>
<term>Protocoles de polychimiothérapie antinéoplasique (effets indésirables)</term>
<term>Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique)</term>
<term>Radiothérapie ()</term>
<term>Radiothérapie (effets indésirables)</term>
<term>Seconde tumeur primitive (épidémiologie)</term>
<term>Seconde tumeur primitive (étiologie)</term>
<term>Survivants</term>
<term>Thrombose ()</term>
<term>Traitement médicamenteux adjuvant (effets indésirables)</term>
<term>Troubles de la cognition ()</term>
<term>Tumeurs de l'endomètre ()</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (mortalité)</term>
<term>Tumeurs du sein (radiothérapie)</term>
<term>Tumeurs du sein (traitement médicamenteux)</term>
<term>Tumeurs radio-induites (épidémiologie)</term>
<term>Tumeurs radio-induites (étiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Agents, Hormonal</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenal Cortex Hormones</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term>
<term>Chemotherapy, Adjuvant</term>
<term>Radiotherapy</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Cognition Disorders</term>
<term>Endometrial Neoplasms</term>
<term>Fatigue</term>
<term>Osteoporosis</term>
<term>Primary Ovarian Insufficiency</term>
<term>Thrombosis</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term>
<term>Radiation Pneumonitis</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antinéoplasiques hormonaux</term>
<term>Protocoles de polychimiothérapie antinéoplasique</term>
<term>Radiothérapie</term>
<term>Traitement médicamenteux adjuvant</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Neoplasms, Radiation-Induced</term>
<term>Neoplasms, Second Primary</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Brachial Plexus Neuropathies</term>
<term>Cardiovascular Diseases</term>
<term>Lymphedema</term>
<term>Neoplasms, Radiation-Induced</term>
<term>Neoplasms, Second Primary</term>
<term>Postoperative Complications</term>
<term>Radiation Injuries</term>
<term>Radiation Pneumonitis</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Radiotherapy</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Pneumopathie radique</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Hormones corticosurrénaliennes</term>
<term>Protocoles de polychimiothérapie antinéoplasique</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Seconde tumeur primitive</term>
<term>Tumeurs radio-induites</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Complications postopératoires</term>
<term>Lymphoedème</term>
<term>Lésions radio-induites</term>
<term>Maladies cardiovasculaires</term>
<term>Neuropathies du plexus brachial</term>
<term>Pneumopathie radique</term>
<term>Seconde tumeur primitive</term>
<term>Tumeurs radio-induites</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Mastectomy</term>
<term>Pregnancy</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Survivors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Fatigue</term>
<term>Femelle</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Insuffisance ovarienne primitive</term>
<term>Lymphoedème</term>
<term>Mastectomie</term>
<term>Ostéoporose</term>
<term>Radiothérapie</term>
<term>Survivants</term>
<term>Thrombose</term>
<term>Troubles de la cognition</term>
<term>Tumeurs de l'endomètre</term>
<term>Tumeurs du sein</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The majority of women treated today for breast cancer are long-term survivors. The overall benefits of adjuvant therapy in women with breast cancer favor treatment even in the subset of patients with node-negative invasive breast cancer. The short- and long-term side effects of combined modality treatment have a significant impact on morbidity and quality of life. Continued emphasis on improving survival, decreasing recurrence, and minimizing treatment toxicity are the goals of ongoing breast cancer research.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Ohio</li>
</region>
</list>
<tree><noCountry><name sortKey="Shapiro, Charles L" sort="Shapiro, Charles L" uniqKey="Shapiro C" first="Charles L" last="Shapiro">Charles L. Shapiro</name>
</noCountry>
<country name="États-Unis"><region name="Ohio"><name sortKey="Mrozek, Ewa" sort="Mrozek, Ewa" uniqKey="Mrozek E" first="Ewa" last="Mrozek">Ewa Mrozek</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007E66 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 007E66 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:16166992 |texte= Survivorship and complications of treatment in breast cancer. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:16166992" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |